Serine ADPr on histones and PARP1 is a cellular target of ester-linked ubiquitylation
- PMID: 40634527
- PMCID: PMC12568645
- DOI: 10.1038/s41589-025-01974-5
Serine ADPr on histones and PARP1 is a cellular target of ester-linked ubiquitylation
Erratum in
-
Publisher Correction: Serine ADPr on histones and PARP1 is a cellular target of ester-linked ubiquitylation.Nat Chem Biol. 2025 Nov;21(11):1829. doi: 10.1038/s41589-025-02024-w. Nat Chem Biol. 2025. PMID: 40841496 Free PMC article. No abstract available.
Abstract
ADP-ribosylation and ubiquitylation regulate various cellular processes, with the complexity of their interplay becoming increasingly clear, as illustrated by ADP-ribosylation-dependent ubiquitylation mediated by Legionella. Biochemical studies have reported ester-linked ubiquitylation of ADP-ribose by DELTEX ubiquitin ligases, yet the modification sites on cellular targets remain unknown. Here, our search for interactors of RNF114 revealed DNA-damage-induced serine mono-ADP-ribosylation as a cellular target for ester-linked ubiquitylation. By developing proteomics strategies tailored to the chemical features of this composite modification, combined with an enrichment method using the zfDi19 and ubiquitin interaction motif domain (ZUD) of RNF114 and specific chemical elution, we identified ADP-ribosyl-linked serine ubiquitylation sites in cells, including on histones and poly(ADP-ribose) polymerase 1. Engineering ZUD into a modular reagent enabled the detection of this dual modification by immunoblotting. We establish ADP-ribosyl-ubiquitylation as an endogenous serine post-translational modification and propose that our multifaceted, tailored methodology will uncover its widespread occurrence, along with other conjugation chemistries, across diverse signaling pathways.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: I.M. declares that Max Planck Innovation, which is responsible for technology transfer from Max Planck Institutes, has licensed the antibody AbD43647 to Bio-Rad Laboratories, which markets it for research purposes. I.M., A.K. and M.D.P. are named as inventors on a pending patent application related to the work described in this manuscript. The remaining authors declare no competing interests. Inclusion & ethics statement: All authors fully fulfilled the criteria for authorship required by Nature Portfolio, as their participation was essential for the design and implementation of the study. Roles and responsibilities were agreed among authors ahead of the research. This research does not result in stigmatization, discrimination, incrimination or personal risk to researchers.
Figures
References
-
- Walsh, C. T., Garneau-Tsodikova, S. & Gatto, G. J. Jr. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew. Chem. Int. Ed. Engl.44, 7342–7372 (2005). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
